List News    News

Tunisia endeavours to cover 60% of market needs in medicines in 2020

Published the:  30/04/2018

| Share

(TAP)- Prime Minister Youssef Chahed said Monday that Tunisia is working to cover 60% of the market needs for medicines in 2020 against less than 51% in 2016.

Speaking at the inauguration of the Néapolis Pharma chemotherapy drug production unit in Nabeul, Chahed said his government intends to expand the sales of the drug production units, which will increase the sector turnover to 1350 million dinars by 2020.

He emphasised the need to promote this sector, which generates 9,000 jobs, underlining the importance of Néapolis Pharma as a production unit that employs a specialised workforce and contributes to reducing the export of chemotherapy drugs.

Minister of Health Imed Hammemi, on this occasion, indicated that this unit which has just started production will make a contribution to the sector of pharmaceutical industries, at a time when the number of cancer cases is 14 thousand a year.

With investments worth 50 million dinars, Neapolis Pharma offers a range of products that includes various forms common in the treatment of cancer including dry forms (film-coated tablets and capsules) and sterile injectable forms (bottles containing solutions liquids and / or freeze-dried products).

This subsidiary of the MédiS Group, which currently employs nearly 30 people, will recruit no fewer than 150 people in the near future.

Leading Tunisian pharmaceutical company in turnover, first exporter of the sector (100 million dinars, 25 countries) and with the largest drug control laboratory in the country, Medi is the only multinational Tunisian group.